For founders, angel investors and employees of most early-stage companies, dilution is a necessary evil. For a company to grow and thrive, it must be able to attract outside capital and talent – actions that most likely will require offering equity and diluting the ownership interests of prior investors and team members. The problem is even more serious for those early-stage companies that hit a rough patch in their development and must obtain much-needed investment through a highly dilutive down-round.
Because dilution can be a risk for angel investors and other financing sources, as well as potential employees, top management of early-stage companies often ask how they can minimize dilution. This is possible, albeit difficult. Founders should not be surprised if they have to give up between 10% and 30% of their equity to raise seed capital for a startup. While dilution can be constrained somewhat, as described below, it is important to keep the matter in perspective: Dilution is a normal consequence of a company’s evolution and a key ingredient for future growth and success.
Convertible Instruments Postpone Dilution
One effective means of reducing dilution is by financing growth through the issuance of convertible notes or other convertible debt. In such cases, the exchange ratio will be established and the convertible instrument will convert into equity only after the company has more of an operating history – typically when there is a Series A financing round. Relying on a convertible instrument postpones the inevitable dilution until it is possible to value the business more accurately by a third party – perhaps when the company has a working prototype of its product or service or a beta customer. It can actually be highly efficient to raise capital through a convertible instrument, since the entrepreneurs and investors do not have to wrangle over valuation until a later date.
Establish the Dilution Impact Up Front
Another tactic that can be used to somewhat control dilution is to establish an option pool of equity early on, which the company can use to incentivize current and future employees. I have seen early stage companies set aside an option pool of 10% to 15% of their equity for such purposes and draw down equity from the pool as needed over time. While this may not reduce dilution in the absolute sense, defining the extent of the potential dilution up front does take a great deal of the uncertainty out of the process for founders, angel investors and early-stage employees.
One measure that is not effective is the imposition of anti-dilution provisions in investor term sheets. Since the anti-dilution clauses tie the hands of the company in attracting future investors or other key employees in the future, they are not recommended.
Capital Planning and Efficiency
The best protection against dilution is for a company to exercise discipline in its deployment of capital, so that it will not need to go outside for significant financing. This will require having a well-defined business plan and strategy that anticipates how far a given round of financing will take the business. For example, what level of capital will be needed to get to a working prototype or to the beta phase with a key customer? Clearly delineating these benchmarks and executing the strategy in an efficient and cost-effective manner will increase the likelihood that future fundraising will be up-rounds.
We are now seeing record levels of dry powder available for startups, with some recent estimates exceeding $121 billion at venture capital firms alone, according to Institutional Investor. At the same time, private equity firms are sitting on large pools of capital, which enables young companies to monetize their values by selling to a PE firm instead of through an IPO or other strategic acquirer. This supply (or, arguably, oversupply) of capital has increased valuations and, thus, has a somewhat dampening effect on dilution. As such, elevated valuations may not be sustained over the long term, and once more down-to-earth valuations become the norm it will be important to consider how best to minimize dilution while still supporting growth.
Ram Snir, Ph.D, says
How early in the process can you assist?
Could you please contact me please?.
Richard Russo says
Good article. Might have included a comment about participation rights for angel investors in future rounds. The comment about “record amounts of dry powder available’ is somewhat misleading. It is true for some sectors and completely untrue for others. Also,for life science products (not services), the capital reqiurements are such that “giving up 10% – 30% of initial equity would be best case.